Donors and Partners Discuss the Path Forward for Polio Eradication

Donors and technical partners met to review Pakistan's polio eradication strategy and the resources required to complete it.

Why the funding conversation recurs

Polio eradication has an unusual economic shape. It is a fixed-cost commitment with an uncertain end date: the programme costs roughly the same each year whether transmission stops this year or in five years, and the benefit arrives only at the end. There is no partial credit.

That makes it uniquely exposed to donor fatigue. Every year transmission continues, the total bill for finishing grows, and the case for continued investment has to be made again to the same funders who have already given for decades.

What gets discussed

• Epidemiological status — case counts, environmental surveillance positivity, and the transmission routes sequencing reveals.
• Where money is going — campaign operations, surveillance, the frontline workforce, community engagement and vaccine supply.
• Access — what is being done about the southern Khyber Pakhtunkhwa constraint, which no amount of funding resolves on its own.
• Transition planning — how the polio infrastructure, one of Pakistan's largest health delivery networks, supports routine immunisation and broader health services as the programme eventually winds down.
• Domestic contribution — the balance between external funding and Pakistan's own resourcing.

Who the funders are

The core partnership comprises WHO, Rotary International, the US CDC, UNICEF, the Bill & Melinda Gates Foundation and Gavi. Bilateral and multilateral donors have at various points included the United States, the United Kingdom, Japan, Germany, Canada, the European Union, Saudi Arabia, the United Arab Emirates, the Islamic Development Bank and the World Bank. See partners and donors.

The economic case

Modelling by the eradication partnership has consistently found that finishing costs far less than living with polio indefinitely. A world that stops short would face permanent vaccination costs everywhere, a continuing risk of international spread, and the near-certainty of resurgence — which is the argument that has sustained funding through four decades and several missed target dates.

The transition question

Pakistan's polio programme employs one of the largest health workforces in the country and runs data, cold chain and surveillance systems that reach further than the routine health system does. Planning what happens to that capacity after eradication is a live issue, and one reason the programme increasingly delivers integrated services rather than polio drops alone.

Related: GPEI delegation visit · routine immunisation